Sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide
C12H18N7NaO7S2 — CID 159575791
Data last refreshed: (MolForge compound catalog, from PubChem)
About Sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide
Sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide (PubChem CID 159575791) has the molecular formula C12H18N7NaO7S2 and a molecular weight of 459.44 g/mol. Its IUPAC name is sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide.
Molecular Properties
| Compound Name | Sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide |
|---|---|
| PubChem CID | 159575791 |
| Molecular Formula | C12H18N7NaO7S2 |
| Molecular Weight | 459.44 g/mol |
| Exact Mass | 459.06 |
| IUPAC Name | sodium;1-methyl-3-sulfamoylpyrazole-5-carboxylate;N,N,1-trimethyl-3-sulfamoylpyrazole-5-carboxamide |
| SMILES | CN(C)C(=O)c1cc(S(N)(=O)=O)nn1C.Cn1nc(S(N)(=O)=O)cc1C(=O)[O-].[Na+] |
| InChI | InChI=1S/C7H12N4O3S.C5H7N3O4S.Na/c1-10(2)7(12)5-4-6(9-11(5)3)15(8,13)14;1-8-3(5(9)10)2-4(7-8)13(6,11)12;/h4H,1-3H3,(H2,8,13,14);2H,1H3,(H,9,10)(H2,6,11,12);/q;;+1/p-1 |
| InChIKey | MIJQSIBEDIYVRG-UHFFFAOYSA-M |
| XLogP | -6.80 |
| TPSA | 216.40 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.44 |
| LogP ≤ 5 | -6.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159575791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.